Format

Send to

Choose Destination
J Feline Med Surg. 2012 Aug;14(8):566-72. doi: 10.1177/1098612X12446211. Epub 2012 May 2.

Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control.

Author information

1
Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg.

Abstract

The aim of this study was to report outcomes using detemir and a protocol aimed at intensive blood glucose control with home monitoring in diabetic cats, and to compare the results with a previous study using the same protocol with glargine. Eighteen cats diagnosed with diabetes and previously treated with other insulins were included in the study. Data was provided by owners who joined the online German Diabetes-Katzen Forum. The overall remission rate was 67%. For cats that began the protocol before or after 6 months of diagnosis, remission rates were 81% and 42%, respectively (P = 0.14). No significant differences were identified between the outcomes for the glargine and detemir studies, with the exception of three possibly interrelated factors: a slightly older median age of the detemir cohort at diabetes diagnosis, a higher rate of chronic renal disease in the detemir cohort and lower maximal dose for insulin detemir.

PMID:
22553309
DOI:
10.1177/1098612X12446211
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center